PT - JOURNAL ARTICLE AU - Yamada, Norihiro AU - Tominaga, Kana AU - Tominaga, Naoomi AU - Kobayashi, Ayumi AU - Niino, Chihiro AU - Miyagi, Yuta AU - Yamagata, Hirotaka AU - Nakagawa, Shin TI - Glycosylation state of vWF in circulating extracellular vesicles serves as a novel biomarker for predicting depression AID - 10.1101/2024.03.24.24304794 DP - 2024 Jan 01 TA - medRxiv PG - 2024.03.24.24304794 4099 - http://medrxiv.org/content/early/2024/03/26/2024.03.24.24304794.short 4100 - http://medrxiv.org/content/early/2024/03/26/2024.03.24.24304794.full AB - The clinical diagnosis of major depressive disorder (MDD), a heterogeneous disorder, still depends on subjective information in terms of various symptoms regarding mood. Detecting extracellular vesicles (EVs) in blood may result in finding a diagnostic biomarker that reflects the depressive stage of patients with MDD. Here, we report the results on the glycosylation pattern of enriched plasma EVs from patients with MDD and age-matched healthy subjects. In this cohort, the levels of Triticum vulgaris (wheat germ) agglutinin (WGA), N-acetyl glucosamine (GlcNAc) and N-acetylneuraminic acid (Neu5Ac, sialic acid) - binding lectin, were significantly decreased in patients with MDD in depressive state compared to healthy subjects (area under the curve (AUC): 0.87 (95% confidence interval (CI) 0.76 - 0.97)) and in remission state (AUC: 0.88 (95% CI 0.72 - 1.00)). Furthermore, proteome analysis revealed that the von Willebrand factor (vWF) was a significant factor recognized by WGA. WGA-binding vWF antigen differentiated patients with MDD versus healthy subjects (AUC: 0.92 (95% CI 0.82 - 1.00)) and the same patients with MDD in depressive versus remission state (AUC: 0.98 (95% CI 0.93 - 1.00)). In this study, the change patterns in the glycoproteins contained in plasma EVs support the usability of testing to identify patients who are at increased risk of depression during antidepressant treatment.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research was supported partly by Japan Agency for Medical Research and Development (grant number 22dk0307103h0002) and the the Strategic Research Program for Brain Sciences (Integrated Research on Neuropsychiatric Disorders). K.T. received support from SENSHIN Medical Research Foundation, Japan and The Finding-Out & Crystallization of Subliminals (FOCS) project by the Yamaguchi University of Medicine. This work was also the result of using program for supporting construction of core facilities in MEXT Project for promoting public utilization of advanced research infrastructure (grant number JPMXS0440400023).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Institutional Review Board of Yamaguchi University Hospital, Yamaguchi, Japan gave ethical approval for this work (H25-085-13, H23-153-19, H2022-203), and all subjects provided written informed consent for participation.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data in this article (and its Supplementary Information files) are available. The other data analyzed in the current study are not publicly available for ethical reasons.